The use of anti-CD20 chimeric monoclonal antibody, rituximab in adult patients with treatment refractory immune thrombocytopenia

被引：0
|
作者：
Jacoub, J
Mchlayeh, W
Tabbara, I
Dave, HP
Siegel, R
Schechter, GP
机构：
[1] George Washington Univ, Washington, DC USA
[2] Vet Affairs Med Ctr, Washington, DC USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3950
引用
收藏
页码：74B / 74B
页数：1
相关论文
共 50 条
  • [21] A fixed, low dose of anti-CD20 antibody (Rituximab) is an effective treatment for patients with chronic immune thrombocytopenia
    El-Najjar, I
    Rule, SAJ
    Nokes, TJC
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 79 - 80
  • [22] Single dose of Anti-CD20 monoclonal antibody (rituximab) treatment in adults with refractory immune thrombocytopenic purpura (ITP).
    Tanaka, Eri
    Hayashi, Shuji
    Fujimaki, Katsumichi
    Fujita, Hiroyuki
    BLOOD, 2006, 108 (11) : 321A - 321A
  • [23] Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease
    Ratanatharathorn, V
    Carson, E
    Reynolds, C
    Ayash, LJ
    Levine, J
    Yanik, G
    Silver, SM
    Ferrara, JLM
    Uberti, JP
    ANNALS OF INTERNAL MEDICINE, 2000, 133 (04) : 275 - 279
  • [24] Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura
    Stasi, R
    Pagano, A
    Stipa, E
    Amadori, S
    BLOOD, 2001, 98 (04) : 952 - 957
  • [25] Treatment of pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab)
    Herrmann, G
    Engert, A
    Hunzelmann, N
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (03) : 602 - 603
  • [26] A Novel Anti-CD20 Monoclonal Antibody for Treating Relapsed Immune Thrombocytopenia
    Liu, Jia
    Yao, Han
    Tao, Jun
    Feng, Yimei
    Zhang, Xi
    BLOOD, 2024, 144
  • [27] Successful use of anti-CD20 monoclonal antibody (Rituximab) for life-threatening refractory childhood immune thrombocytopenic purpura
    Bengston, KL
    Skinner, MA
    Ware, RE
    PEDIATRIC RESEARCH, 2002, 51 (04) : 241A - 241A
  • [28] Successful treatment of refractory low grade duodenal lymphoma with rituximab, an anti-cd20 monoclonal antibody
    Ahmed, S
    Singh, A
    Krauss, J
    Wentz, T
    Gunaratnam, NT
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : 408 - 410
  • [29] Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: Efficacy and safety of treatment
    Parodi, Emilia
    Nobili, Bruno
    Perrotta, Silverio
    Matarese, Sofia Maria Rosaria
    Russo, Giovanna
    Licciardello, Maria
    Zecca, Marco
    Locatelli, Franco
    Cesaro, Simone
    Bisogno, Gianni
    Giordano, Paola
    De Mattia, Domenico
    Ramenghi, Ugo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2006, 84 (01) : 48 - 53
  • [30] Rituximab (anti-cd20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment
    Emilia Parodi
    Bruno Nobili
    Silverio Perrotta
    Sofia Maria Rosaria Matarese
    Giovanna Russo
    Maria Licciardello
    Marco Zecca
    Franco Locatelli
    Simone Cesaro
    Gianni Bisogno
    Paola Giordano
    Domenico De Mattia
    Ugo Ramenghi
    International Journal of Hematology, 2006, 84 : 48 - 53
12345